<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8" />
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=1.0, maximum-scale=1.0, minimum-scale=1.0, user-scalable=no" />
        <title>5</title>

        <link href="../jquery-mobile/jquery.mobile.theme-1.2.0.min.css" rel="stylesheet" type="text/css"/>
        <link href="../jquery-mobile/jquery.mobile.swatch.f.css" rel="stylesheet" type="text/css"/>
        <link href="../assets/css/custom_arrow.css" rel="stylesheet" type="text/css"/>
        <link href="../jquery-mobile/jquery.mobile.structure-1.2.0.min.css" rel="stylesheet" type="text/css"/>
        <link href="../assets/css/treatments.css" rel="stylesheet" type="text/css"/>
        <link href="../assets/css/recreated_tables.css" rel="stylesheet" type="text/css"/>
        <script src="../jquery-mobile/jquery-1.8.2.min.js" type="text/javascript"></script>
        <script src="../jquery-customization.js" type="text/javascript"></script>
        <script src="../jquery-mobile/jquery.mobile-1.2.0.min.js" type="text/javascript"></script>
        <script src="../cordova-2.2.0.js" type="text/javascript" charset="utf-8"></script>
        <script src="../assets/js/metrics.js" type="text/javascript" charset="utf-8"></script>

    </head>
    </body>
        <!-- Start of condition page -->
        <div data-role="page" id="cond-5-dxtx" data-theme="d">

            <div data-id="quickpick-header" data-role="header" data-theme="f" data-position="fixed">
                <a href="cond-3-children-lv.html" data-role="button" data-theme="reset" data-iconshadow="false" data-corners="false" class="back_button" role="button" aria-label="back"></a>
            
                <h1>Condition Quick Pick</h1>
                <a href="../menu.html" rel="external" data-role="button" data-theme="reset" data-iconshadow="false" data-corners="false" class="menu_button ui-btn-right" role="button" aria-label="main menu"></a>
            </div>  <!-- end of quickpick-header div --> 
            <div data-role="content" data-theme="d" >
                <div id=quickpick_breadcrumbs>
                
                        <a href="cond-0-children-lv.html" >Condition Quick Pick</a><span class="carrot"> > </span>
                        <a href="cond-3-children-lv.html" >Candidiasis - Vulvovaginal</a><span class="carrot"> > </span>Complicated
                </div>   <!-- end of quick pick breadcrumbs -->
                </br><h5 class="sgc-1" id="sigil_toc_id_289">
 Treatment
</h5>
<p>
 Each individual episode of RVVC caused by
 <i>
  C. albicans
 </i>
 responds well to short-duration oral or topical azole therapy. However, to maintain clinical and mycologic control, some specialists recommend a longer duration of initial therapy (e.g., 7&ndash;14 days of topical therapy or a 100-mg, 150-mg, or 200-mg oral dose of fluconazole every third day for a total of 3 doses [day 1, 4, and 7]) to attempt mycologic remission before initiating a maintenance antifungal regimen.
</p>
<h5 class="sgc-1" id="sigil_toc_id_290">
 Maintenance Regimens
</h5>
<p>
 Oral fluconazole (i.e., 100-mg, 150-mg, or 200-mg dose) weekly for 6 months is the first line of treatment. If this regimen&nbsp;is not feasible, topical treatments used intermittently as a maintenance regimen can be considered.
</p>
<p>
 Suppressive maintenance antifungal therapies are effective in reducing RVVC. However, 30%&ndash;50% of women will have recurrent disease after maintenance therapy is discontinued. Routine treatment of sex partners is controversial.
 <i>
  C. albicans
 </i>
 azole resistance is rare in vaginal isolates, and susceptibility testing is usually not warranted for individual treatment guidance.
</p>
<h4 class="sgc-1" id="sigil_toc_id_291">
 Severe VVC
</h4>
<p>
 Severe vulvovaginitis (i.e., extensive vulvar erythema, edema, excoriation, and fissure formation) is associated with lower clinical response rates in patients treated with short courses of topical or oral therapy. Either 7&ndash;14 days of topical azole or 150 mg of fluconazole in two sequential doses (second dose 72 hours after initial dose) is recommended.
</p>
<h4 class="sgc-1" id="sigil_toc_id_292">
 Nonalbicans VVC
</h4>
<p>
 The optimal treatment of nonalbicans VVC remains unknown. Options include longer duration of therapy (7&ndash;14&nbsp;days) with a nonfluconazole azole drug (oral or topical) as first-line therapy. If recurrence occurs, 600 mg of boric acid in a gelatin capsule is recommended, administered vaginally once daily for 2 weeks. This regimen has clinical and mycologic eradication rates of approximately 70% (380). If symptoms recur, referral to a specialist is advised.
</p>

            <div data-role="footer" data-id="regimens-footer" data-position="fixed" class="tab_treatment">
                <div data-role="navbar" class="tab_icons" data-iconpos="left">
                    <ul>
                        <li><a href="#" class="ui-disabled" id="treat_active" data-icon="custom">Treatments</a></li>
                        <li><a href="#" id="info_active"  class="ui-btn-active ui-state-persist" data-icon="custom">More Info</a></li>
                    </ul>
                </div><!-- /navbar -->
            </div><!-- /footer -->

        </div><!-- end of content -->

        <script type="text/javascript">

            $('#cond-5-dxtx').live('pageshow', function (event, ui) {
                document.addEventListener("deviceready", function(){
                    trackConditionQuickPickDxTxPageView(5);
                                                },true);
                });
        </script>

    </div><!-- end of treatments page -->

</body>
</html>
